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Abstract 
In brain and many other tissues, Type I inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase i  the major isozyme hydrolysing the calcium-mobilizing 
second messenger InsP3. We recently reported the cloning and expression of dog thyroid InsP3 5-phosphatase. During the course of this cloning, 
screening of a human brain eDNA library allowed us to isolate a eDNA clone D1 with 91% sequence identity with the thyroid sequence. When clone 
DI was expressed in Escherichia coli, the fusion protein had InsP3 5-phosphatase activity. Mr estimates of the recombinant enzyme made by 
immunodetection, activity assay after SDS/PAGE or silver staining were consistent with the calculated molecular mass. In situ hybridization on human 
cerebellum sections localised the mRNA for this enzyme to the Purkinje cells. 
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1. Introduction 
It is generally accepted that the phosphoinositide (PI) 
turnover system acts as a signal transducing cascade in 
the central nervous system. Many neurotransmitter r -
ceptors coupled with G protein activate phospholipase 
C, which hydrolyzes phosphatidylinositol 4,5-bis-phos- 
phate, generating inositol 1,4,5-trisphosphate (InsP3) 
and 1,2-diacylglycerol (DAG). InsP3 releases Ca 2÷ 
from intracellular stores whereas DAG activates protein 
kinase C [1]. InsP3 5-phosphatase catalyzes the 
dephosphorylation of InsPa inactivating the signal. This 
enzyme is present at high concentration i the brain, 
particularly in the cerebellum [2,3]. Regulation of this 
enzyme will directly modify InsPa accumulation and 
Ca 2+ signalling. To study this reaction, we aimed to clone 
cDNAs encoding InsP3 5-phosphatase in brain tissue. 
We present here for the first time cloning, expression and 
production of recombinant Type I InsP3 5-phosphatase 
from human brain. We also show its localisation in cer- 
ebellar Purkinje cell bodies. 
2. Materials and methods 
(Stratagene) as reported in [4]. To express D1 as a fl-galactosidase fusion 
product, the following construct was made by PCR using the following 
sense and antisense primers: ATCGGATCCGATGGCGGGGAAG- 
GCGC~C and ATCGAATTCAAGTGTGGGCd2CGGCCGTCTA. 
Plasmid DNA of D1 was subjected to PCR to amplify a 1,376 bp 
product. This material was subeloned into Bluescript after digestion 
with EcoRI and BamHI. The in-frame clone derived from D1 is now 
referred to as ECHI. To express the recombinant enzyme from ECH1 
plasmid, LB medium (31) containing 50/zg/ml ampicillin was inoculated 
for an overnight incubation at 37"C with a single colony of E. coli 
containing the Blueseript ECH1 plasmid. After addition of isopropyl 
fl-thiogalactoside (1 mM final concentration) for 2.5 h at 30"C, the 
bacteria were harvested by centrifugation (1,200 x g, 15 rain) and resus- 
pended in 250 ml of cold lysis buffer (20 mM Tris-HC1, pH 8, 1 mM 
EDTA, 50 mg/l pefabloc, 2.5/tM leupeptin, 10% sucrose, 12 mM 
2-mercaptoethanol and 1% Triton X-100). After agitation for 60 min 
at 4"C and centrifugation (15,000 x g, 15 min), supernatant was used 
for further purification. The crude lysate (activity of about 50-120 
/zmol/min assayed at 10/zM IusP3) was loaded onto a Blue-Sepharose 
column (14 x 5 era) equilibrated inBD buffer (20 mM Tris-HCl, pH 7.5, 
0.1 mM EGTA, 2 mM MgC12, 10% glycerol and protease inhibitors). 
After washing with 100 mi of BD buffer, the enzyme was duted with 
a linear gradient of 0-1 M NaCI of 1 I (total volume). After concentra- 
tion to 10 ml, further purification was achieved by Sephacryl S-200 gel 
filtration [5]: At this step, specific activity was 1.25/~mol/min/mg at 10 
/zM InsP3. The pooled fractions were concentrated to 10 mi (1/zmol/ 
min/mi). An afiquot of this preparation (0.25 ml) was six-fold iluted 
in 20 mM Na acetate, pH 5.5, and further purified onto a CM Mem 
Sep HP 1000 cation exchange HPLC resolved by a gradient of NaCI 
(0-0.2 M). Materials, assay of IusP3 5-phosphatase activity, Western 
blotting and immunodetection of proteins were as previously described 
[5-6]. 
2.1. Molecular cloning and expression of human brain I sP 3 
5-phosphatase 
The cloning of human brain Type I IusP3 5-phosphatase (clone D1) 
resulted from a screening of a human brain frontal cortex eDNA library 
* Corresponding author. Fax: (32) (2) 555 4655. 
2.2. In situ hybridization 
In situ hybridization was performed on three human cerebella ob- 
tained at autopsy, as outlined in [7]. Three olignnucleotides complemen- 
tary to bases 164-212, 373-419 and 674-720 of clone D1 were radiola- 
beled with [ct35S]dATP. They exhibit identical distribution but with 
different intensities (Fig. 4A-C). To enhance the signal, they were 
mixed 1:1:1 (Fig. 3A). In situ hybridization of the IusP 3 receptor 
mRNAs was performed on adjacent sections with oligonucleotides de- 
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fined in [8] (Fig. 4D). Pretreatment of the sections with RNAse (20 
pg/ml) and hybridization with labeled probes and a 100-fold excess of 
cold relevant probes (Fig. 3D) abolished the signal in contrast to total 
signal persistence in the presence of an excess of unrelated cold probes. 
3. Results 
3.1. Molecular cloning and nucleotide sequencing of 
human brain Type I InsP~ 5-phosphatase 
A human brain frontal cortex eDNA library in phage 
Lambda ZAP II was screened to isolate a eDNA clone 
D1 of 1,564 bp together with four other clones with 
comparable restriction maps. Sequencing of clone D1 
identified a 1,236 bp open reading frame encoding a 412 
amino acid protein with a calculated molecular mass of 
47,817 including the initiating methionine. Fig. 1 shows 
the sequence of the human brain InsP3 5-phosphatase. 
When translated into protein, the coding sequence 
showed an overall 97% identity with the thyroid se- 
quence ([4], similarity in terms of nucleic acids was 91% 
in the coding region). In particular, peptide sequences 
previously reported for the bovine brain enzyme [4] were 
found in the sequence of the human clone (13 peptide 
sequences underlined in Fig. 1 with a total of 135 over 
142 residues conserved between the two species). A com- 
puter search at the NCBI using the Blast network service 
revealed no significant similarities with other proteins. 
However, a partial and unidentified sequence (T08974) 
derived from a human eDNA was found to match the 
3' end sequence of clone D1 over 403 bp (96% identity). 
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Fig. 1. Primary sequence of human brain I sP3 5-phosphatase asde- 
duced from its nucleotide sequence (EMBL Accession Number 
X77567). 
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Fig. 2. (A) Regeneration of activity after SDS/PAGE of InsP3 5-phos- 
phatase expressed in E. coil A sample of partially purified enzyme after 
Blue Sepharose and Sephaeryl S-200 was applied to an SDS/10% poly- 
acrylamide 10 cm slab gel. Activity applied onto the gel was 8 nmol/60 
rain incubation when assayed in the presence of sample buffer used for 
electrophoresis [5]at 10/2M InsP 3 substrate l vel. Activity of the peak 
fraction (i.e. fraction 10) was 1.1 nmol/60 min incubation. (13) Western 
blot analysis of expressed 5-phosphatase. Lane 1: purified enzyme (ap- 
prox. 25/~g or 0.16/tmol/min at 10/tM InsP3 substrate l vel). Lane 2: 
bacterial lysate derived from a non-recombinant clone (approx. 300 
fig). Immunoblot analysis was performed using crude serum [6] diluted 
200-fold. (C) Silver staining of 6 pg purified enzyme. 
3.2. Expression in E. coli 
To confirm that the eDNA clone obtained id indeed 
code for an InsP3 5-phosphatase, the coding sequence 
was amplified by PCR and subcloned into Blueseript 
plasmid (ECH1 done). Apparent Km value for InsP3 
of the expressed protein was 65 pM which is twice the 
Km of the recombinant thyroid enzyme [4]. We verified 
that the activity was inhibited by InsP4 and 2,3- 
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Fig. 3. Representative autoradiograms of adult cerebellum hybridized with the 5-phosphatase radiolabelled ofigonucleotides with a mixture of three 
oligonucleotides (A-C) and its control in the presence of an excess relevant cold probes (D). (C,D) Dark field microscopy. Abbreviations: GL, granular 
layer; ML, molecular layer; Purkinje neuronal cell bodies (arrows) and proximal dendrites (arrowheads); WM, white matter. Bar = 50/zm. 
bisphosphoglycerate s xpected considering the phar- 
macology of Type I InsP3 5-phosphatase (r f. [5]; IC 50 
at 10/zM InsP3 were 10/zM and 1 raM, respectively). 
As the ]~-galactosidase fragment fused to the insert of 
clone ECH1 has a Mr of 4,000-5,000, we estimate the 
total Mr of the expressed protein to be 51,000. A series 
of experiments have identified the recombinant protein 
with an apparent Mr of 43-45 kDa on SDS gels. The 
E. coil-derived InsP3 5-phosphatase activity could be re- 
generated after SDS polyacrylamide g l electrophoresis. 
A single peak of activity comigrated with the standard 
of ovalbumin (Mr 43 _ 3 kDa) (Fig. 2A). InsP3 5-phos- 
phatase antibodies directed against he native bovine 
brain enzyme [6] reco~iTed, on Western blots, a 45 _+ 2 
kDa band in purified lysates derived from expressed 
ECH 1. When the experiment was repeated with a lysate 
derived from a non-recombinant clone which did not 
contain 5-phosphatase activity, no signal was detected 
on immunoblot (Fig. 2B). Purification of the recombi- 
nant enzyme followed by silver staining shows the pres- 
ence of a polypeptide at the same apparent Mr (45 _+ 2 
kDa; Fig. 2C). 
3.3. In situ hybridization 
InsP 3 5-phosphatase mRNA was found in the Purkinje 
cells neuronal bodies (Fig. 3A-C), in their proximal den- 
drites (Fig. 3B) and to a much lesser extent in the granule 
cell layer (Fig. 3A-C). We verified that a similar distribu- 
tion was obtained using three probes separately (Fig. 
4A-C) and that the pattern was different from that of 
InsP3 receptor mRNAs using the same technique (Fig. 
4D). In the case of the InsP3 receptor, the signal is only 
found in the Purkinje cells, while in the case of InsP3 
5-phosphatase it is detected on these neurons but also to 
a lesser extent on the granule cell layer. 
4. Discussion 
There are several lines of evidence for the participation 
of InsP3/Ca 2+ signalling in neuronal function. It is known 
that glutamate stimulates Pi turnover and InsP3 accumu- 
lation in Purkinje cells [9]. Purkinje neurons of the cere- 
bellar cortex contain a particularly high density of InsP3 
receptors [10]. In these cells, InsP3 metabolizing enzymes 
may be involved in Long-term depression of the parallel 
fiber-Purkinje cell glutamate synaptic transmission [11]. 
To study these enzymes, our aim was to clone cDNAs 
encoding the proteins, particularly InsP3 5-phosphatase 
and have adressed the question of the existence of possi- 
ble isozymes. In this study, we report the sequence of 
human brain Type I enzyme. The protein sequence is
97% identical with the previously reported og thyroid 
enzyme suggesting together with biochemical data 
[4,12,13], that this enzyme is widely expressed in various 
tissues. The high levels ofmRNA in the Purkinje neurons 
are consistent with the high activity observed in cerebel- 
lum over other brain areas [3]. Since the enzyme could 
easily be produced in E. coli, it is now possible to study 
its regulation and importance in the Ca 2+ release mecha- 
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Fig. 4. Specificity of in situ hybridization as shown with each 5-phosphatase probe separately (A-C) and InsP3 receptor (D). 
nism. It will also be possible to compare its expression 
in Purkinje neurons and other cells. In this context, re- 
cent data have shown a functional difference in InsPa- 
evoked Ca 2÷ release between Purkinje cells and periph- 
eral tissues [14]. 
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